“Physical Twins” of Human Arteries Predict Individual Stroke Risk 

Scientists in Australia have developed an artery-on-a-chip platform that can replicate a patient’s exact vascular structure to better assess their risk of ischemic stroke. Results published today in Cell Biomaterials show that differences in artery shape explain significant differences in stroke risk seen between patients with similar levels of artery narrowing. 

“Our findings suggested that three-dimensional vascular shape and local flow disturbances matter far more than simple narrowing,” said Yunduo Charles Zhao, graduate student at the University of Sydney and the Heart Research Institute in Newtown, Australia. “We hope these tools will allow us to study drugs aimed at reducing the risk of stroke and to eventually provide personalized treatments for each patient based on their anatomy.” 

Despite significant advances in imaging and management, stroke risk stratification is still very imprecise. Nearly 20% of patients receiving what is considered an optimal antiplatelet therapy continue to experience recurrent strokes, reflecting an incomplete understanding on how complex mechanical and biological factors determine whether clots grow, stabilize, or cause a stroke. 

“This idea was born out of a critical clinical gap,” said Lining Arnold Ju, PhD, associate professor at the University of Sydney in Australia and senior author of the study. “We know that even patients at ‘low risk’ can suffer from severe or fatal strokes. We wanted to find a better way to predict this risk.” 

Ju’s team used high-resolution 3D printing to create a “physical twin” that replicated the three-dimensional structure of the carotid artery from six patients who had previously experienced stroke of the carotid artery. To capture the full complexity of each patient’s unique physiology, the model also included the thrombogenic matrix and endothelium tissues, and simulated blood flow through the chip. 

“Our work recreates precise, patient-specific carotid artery geometries,” said Ju. “The physical twin also uses cells that more closely mimic the dynamics of blood flow in these structures.”

Using computer simulations, the researchers modeled blood flow through each carotid artery, uncovering substantial differences in local blood flow despite similar degrees of narrowing. They then used a laser to create an injury in the physical twins and study how blood clots formed, revealing that subtle differences in an artery’s shape could lead to strikingly different clotting responses. 

The researchers are currently recruiting patients with a stroke history for a clinical trial designed to evaluate the potential of this technology to improve diagnosis and treatment in underserved stroke patients. Down the line, the artery-on-a-chip physical twins could find applications in other cardiovascular conditions, such as peripheral artery disease, deep-vein thrombosis, and aneurysms. 

 

The post “Physical Twins” of Human Arteries Predict Individual Stroke Risk  appeared first on Inside Precision Medicine.

<![CDATA[ASCP updates spotlight ketamine safety guardrails, at‑home agitation therapy, psilocybin phase 3 momentum, and biomarker-driven precision psychiatry.]]>
<![CDATA[Top 2026 psychiatry conference takeaways: mixed-feature bipolar care, GLP-1 addiction trials, schizophrenia adherence, TD gaps, AI prodrome screening.]]>
<![CDATA[SIRS highlights new schizophrenia advances: LB-102 shows promise, Cobenfy switching stays stable, and tazbentetol targets synaptic regeneration.]]>

The Download: energy transmission and US threats against Chinese AI

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.

The power line that could reshape New York’s grid is hitting snags 

During a heat wave on July 3, New York State’s grid imported enough electricity from Canada to meet about 9% of its total demand that day.

Some of that power shuttled in on a 339-mile power line stretching from Quebec to Queens. It opened in May and is officially the longest underground transmission line in North America. It could provide up to 20% of New York City’s electricity demand, largely with abundant hydropower from Quebec.

One wrinkle: The line has been down for most of this month, and some experts are concerned about how drought will affect the power supply feeding it. 

Still, the line could help shape the future of our grid, if it can overcome these sorts of snags. Read our story to understand how.

—Casey Crownhart

This story is from The Spark, our weekly climate tech newsletter. Sign up to receive it in your inbox every Wednesday.

The must-reads

I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.

1 The US Treasury is threatening to sanction Chinese AI companies
Treasury secretary Scott Bessent has accused Moonshot of improperly distilling Anthropic’s Fable model. (TechCrunch)
+ Nvidia’s Jensen Huang is arguing that America has nothing to fear from Chinese AI. (Axios)
Like it or not, Chinese models are now part of the global AI infrastructure. (Rest of World)
+ China’s AI models have Trump’s AI world at war with itself. (MIT Technology Review)

2 Why the OpenAI hack is the scariest AI mishap yet
AI’s capabilities seem to be starting to outpace our current ability to control them. (The Economist $)
+ Hugging Face had to turn to a Chinese AI model to rescue it from the hack. (BI)

3 Visually impaired Europeans can now get an implant that restores sight
And Americans may not have to wait long to receive it, too. (STAT)
+ This retina implant lets people with vision loss do a crossword puzzle. (MIT Technology Review)

4 A bellwether lawsuit suing Meta for social media addiction has been dropped
There are, however, many more waiting in the wings. (NYT $)

5 Here’s how ICE gets its hands on Americans’ data
As soon as you open a credit card or phone account, its agents can see where you live. (404 Media)
States are warring with the Trump administration over the right to see ICE agents’ faces. (Wired $)

6 We urgently need to grapple with AI’s environmental impact
As the world warms, is the price we’re paying worth it? (The Verge)
We did the math on AI’s energy footprint. (MIT Technology Review)

7 Privacy issues with smart glasses need an industrywide fix
That’s according to Samsung, which is unveiling glasses it developed with Google this fall. (Bloomberg $)

8 The US Army is begging soldiers to limit their AI use
The token crisis comes for us all eventually, it seems. (Ars Technica)

9 Why does lettuce keep making Americans sick? ??
It’s pretty simple: a lot of people eat it, and it doesn’t get cooked. (Wired $)

10 Pokemon Go is the perfect game to play this summer
It’s fun, collaborative, and it gets you outdoors. (Guardian)

Quote of the day

“It went off and did this hack all by itself, as far as we can tell. This is the highest level of autonomy that we’ve seen in the use of a large language model for cyber operations.”

—Colin Shea-Blymyer, a cybersecurity research fellow at Georgetown University, tells NPR why the OpenAI hack on Hugging Face is so alarming. 

One More Thing

a helicopter with two passengers flies away from a crowd of professionally dressed people looking after it

KAGAN MACLEOD

Welcome to the dark side of crypto’s permissionless dream 

Jean-Paul Thorbjornsen is a founder of THORChain, a blockchain through which users can swap one cryptocurrency for another and earn fees from making those swaps.  

But is he responsible for what it’s used for? It’s a question that matters because in January last year, its users lost more than $200 million in cryptocurrency after THORChain transactions and accounts were frozen by an admin override, which users believed was not supposed to be possible given the decentralized structure. It’s also been used by North Korean hackers to move $1.2 billion of stolen ethereum. 

Thorbjornsen explains this all away as a function of THORChain’s decentralized and permissionless nature. Read our story exploring whether we should believe him or not. 

—Jessica Klein

We can still have nice things

A place for comfort, fun, and distraction to brighten up your day. (Got any ideas? Drop me a line.)

+ A musician developed an ingenious way to strum a guitar with an electric fan.
Ukraine’s tunnel of love is a leafy green corridor of romance that’s straight out of a fairy tale.
+ The driver of a giant banana has been pulled over 100s of times, but still won’t ditch his treasured ride.
+ Ever wonder which albums and songs truly stand the test of time? The Greatest Music tries to answer that via an algorithm that analyses hundreds of “best of” lists.

Intraocular pressure spikes after intravitreal injection and their impact on OCT angiography

PurposeTo evaluate whether acute intraocular pressure (IOP) elevation after intravitreal anti-VEGF injection affects superficial capillary plexus (SCP) perfusion metrics on optical coherence tomography angiography (OCTA).MethodsIn this prospective single-center study, adults scheduled for unilateral intravitreal anti-VEGF treatment for macular edema were enrolled. Assessments were performed pre-injection (T1), early post-injection (T2), and 10 min after T2 (T3). OCTA (CIRRUS HD-OCT 5000; AngioPlex Metrix v11.0) used 6 × 6 mm fovea-centered scans. SCP vessel density (VD) and perfusion density (PD) were quantified for central (1 mm), inner (3 mm), and full macular fields (ETDRS grid). IOP was measured at T1–T3. Scans with signal strength index (SSI) < 6 or relevant motion/segmentation artefacts were excluded. Spearman correlation and multivariable regression analysis assessed associations of VD/PD with IOP and SSI.ResultsOf 81 recruited subjects, 54 eyes (66.7%) finally met OCTA quality criteria at all timepoints and were analyzed. Mean IOP increased from 13.98 ± 3.09 mmHg (T1) to 31.15 ± 9.65 mmHg (T2; p < 0.0001) and decreased to 16.30 ± 4.60 mmHg at T3 (p = 0.6246 vs. T1). Full-field SCP VD and PD decreased from 15.07 ± 3.01 and 36.23 ± 7.60 (T1) to 13.76 ± 3.50 and 33.21 ± 9.08 (T2), and to 13.22 ± 2.99 and 31.73 ± 7.67 (T3). Between T1 and T2, no OCTA parameter changed significantly. At T3, all SCP parameters were significantly lower versus at T1 except for central VD (p = 0.1495) and central PD (p = 0.2894). SSI declined from 8.35 ± 1.39 (T1) to 7.72 ± 1.42 (T2; p = 0.0105) and 7.09 ± 1.38 (T3; p < 0.0001). Correlations between VD/PD and IOP were weak (rs ≤ 0.17), whereas correlations with SSI were moderate-to-strong (rs = 0.53–0.83).ConclusionIntravitreal anti-VEGF injection caused a marked acute IOP spike, but most SCP OCTA metrics did not change at T2. The decline in SCP metrics at T3 coincided with reduced SSI and correlated more strongly with image quality than with IOP, indicating that post-procedural OCTA image quality may influence measured perfusion metrics; however, in the absence of blood pressure measurements, a physiological contribution cannot be excluded.

Delayed multiple hemorrhagic brain metastases from atrial myxoma: a case report and literature review

ObjectiveBrain metastases from atrial myxoma are rare central nervous system manifestations and may mimic hemorrhagic malignant metastases or vascular lesions. We report a delayed case after prior cardiac myxoma resection and summarize the available patient-level literature.MethodsWe retrospectively reviewed the clinical course, multimodal neuroimaging, surgical findings, histopathology, immunohistochemistry, vascular imaging, and follow-up of a woman in her early 70s. A literature review was performed using PubMed, Web of Science, Embase, and Google Scholar from inception to 19 June 2026 with search terms related to cardiac/atrial myxoma, brain/intracranial metastasis, brain metastases, implantation, and cerebral aneurysm. Cases with histologically confirmed intracranial parenchymal myxomatous lesions were included.ResultsThe patient presented with recurrent dizziness, gait instability, right-sided weakness, and incomplete homonymous hemianopia. Brain lesions were detected 5 months after surgical resection of a left atrial myxoma, and echocardiography showed no local recurrence of the cardiac tumor. Brain CT and MRI demonstrated multiple hemorrhagic enhancing lesions with perilesional edema involving the cerebellar vermis, left occipital lobe, and other cerebral and cerebellar regions. Preoperative CTA showed no suspicious intracranial aneurysm. Two representative symptomatic lesions were surgically removed because of diagnostic uncertainty and local mass effect, whereas the remaining multifocal hemorrhagic lesions were managed with close radiological surveillance. Histology showed spindle/stellate cells in abundant myxoid stroma, and immunohistochemistry was positive for calretinin and CD31 but negative for GFAP and desmin, supporting brain metastases from atrial myxoma. At 6-month follow-up, MRI showed no local recurrence and repeat CTA showed no suspicious aneurysm.ConclusionDelayed hemorrhagic brain metastases from atrial myxoma should be considered when patients with a history of cardiac myxoma develop new neurological symptoms and multiple hemorrhagic enhancing brain lesions. Diagnosis requires integration of clinical history, neuroimaging, vascular imaging, radiology-pathology correlation, and immunohistochemistry. Treatment and surveillance should be individualized because embolic stroke, myxomatous aneurysms, and parenchymal metastases may coexist and recurrence can occur after long latency.

Vagus nerve–driven microbiota homeostasis: a promising integrative add-on therapy for neurodevelopmental disorders

Over the past two decades, the conceptualization of neurodevelopmental disorders (NDDs) has undergone a profound transformation, shifting from a primarily brain-centric framework toward a systems-level perspective that integrates peripheral physiological processes. Among these, the gut microbiota has emerged as a critical determinant of neurodevelopmental trajectories. Through its involvement in immune modulation, metabolic signaling, and neural communication, the microbiota–gut–brain axis (MGBA) exerts a pervasive influence on brain maturation and function. A growing body of evidence indicates that early-life disruptions of microbiota composition—commonly referred to as dysbiosis—are associated with an increased risk of NDDs, including autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and epilepsy. These disruptions are frequently driven by environmental exposures such as antibiotic use, cesarean delivery, dietary patterns, and psychosocial stress. Despite the expanding recognition of these associations, current therapeutic strategies aimed at restoring microbiota balance, including probiotics and fecal microbiota transplantation, have yielded inconsistent and often transient results. In this context, Vagus Nerve Stimulation (VNS), particularly in its non-invasive forms (nVNS), has emerged as a promising approach capable of modulating environmental exposures through the host-centered regulatory mechanisms of the MGBA. By influencing autonomic tone, activating the cholinergic anti-inflammatory pathway, and modulating neurotransmitter systems, nVNS may restore microbiota homeostasis while simultaneously improving neurodevelopmental outcomes. This article provides a comprehensive and integrative review of the mechanistic, preclinical, and clinical evidence supporting the role of nVNS as a microbiota-modulating intervention. We further discuss its potential as a safe, cost-effective and promising therapeutic strategy for neurodevelopmental disorders, with a particular emphasis on pediatric populations.